Rigel Announces Five Presentations at the EHA2024 Hybrid Congress ...Middle East

PR Newswire - News
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
- Oral presentation highlighting final five-year efficacy data from the registrational Phase 2 trial of REZLIDHIA® (olutasidenib) in heavily pretreated patients with R/R mIDH1 AML, including those receiving prior venetoclax - New data shows clinically meaningful effect of olutasidenib in...

Hence then, the article about rigel announces five presentations at the eha2024 hybrid congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Rigel Announces Five Presentations at the EHA2024 Hybrid Congress )

Apple Storegoogle play

Last updated :

Also on site :